Mitigation Strategies for Shortages in 503A Thumbnail
HealthOctober 09, 2020

On-Demand Webinar: Mitigation strategies for shortages in 503A compounding pharmacies

Whether your facility outsources or manages shortages in-house, the FDA has developed guidance to help you navigate these complex situations. From appropriate compounding of bulk substances to temporary policies for compounders not registered as outsourcing facilities, there are numerous factors to consider. Eric S. Kastango, MBA, BSPharm, FASHP and Mary Nazzal, PharmD, will walk you through the information the FDA has provided and how your facility can best support the public health effort through these difficult times.

At the conclusion of this webinar, you will be able to:

  • Understand the USP 797 requirements for selection, receipt, and evaluation of all CSP components
  • Discuss mitigation options and frequently asked questions on managing shortages in your sterile compounding facility
  • Identify FDA and other guidance that will assist you with shortages
  • Understand the USP 797 requirements for selection, receipt, and evaluation of all CSP components
  • Discuss mitigation options and frequently asked questions on managing shortages in your sterile compounding facility
  • Identify FDA and other guidance that will assist you with shortages
Access the On-Demand Webinar
Solutions
Simplifi 797®

Take the guesswork out of USP medication compounding compliance with a customizable, mobile, evidence-based solution.

 

Simplifi 797 provides the latest evidence-based guidance and helps navigate the complex USP Chapters 795, 797 and 800 processes to ensure inspection confidence and keep patients and staff safe.